Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?

about

Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?

Item

http://www.wikidata.org/entity/Q55711736

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@en

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@nl

type

Item

label

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@en

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@nl

prefLabel

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@en

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@nl

P1476

Radiotherapy of Glioblastoma 1 ...... Controversies than Standards?

@en

P2093

Adam Dziacky

http://www.w3.org/2001/XMLSchema#string

Marek Slavik

http://www.w3.org/2001/XMLSchema#string

Ondrej Slaby

http://www.w3.org/2001/XMLSchema#string

Pavel Slampa

http://www.w3.org/2001/XMLSchema#string

Petr Burkon

http://www.w3.org/2001/XMLSchema#string

Petr Pospisil

http://www.w3.org/2001/XMLSchema#string

Radek Lakomy

http://www.w3.org/2001/XMLSchema#string

Radim Jancalek

http://www.w3.org/2001/XMLSchema#string

Tomas Kazda

http://www.w3.org/2001/XMLSchema#string

Zdenek Rehak

http://www.w3.org/2001/XMLSchema#string

P2860

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tumor treating fields: a novel treatment modality and its use in brain tumors

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.

Imaging and target volume delineation in glioma.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.

P304

121-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2478/RAON-2018-0023

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30018514

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

6043880

http://www.w3.org/2001/XMLSchema#string